BTK and pancreatic adenocarcinoma: BTK regulates the crosstalk between B cells and FcRγ+ TAMs in the TME and thus TAM-mediated immunosuppression of T cells in pancreatic adenocarcinomas, which can be reverted by treatment with ibrutinib or siRNA-mediated knockdown of BTK (77).